View Older Stories View More Recent Stories

Dec 15, 2022 06:45AM AstraZeneca and Merck Provide Update on US Regulatory Review of LYNPARZA® (olaparib) in Combination With Abiraterone and Prednisone or Prednisolone as Treatment of Metastatic Castration-Resistant Pro
Dec 12, 2022 06:45AM Merck Begins Tender Offer to Acquire Imago BioSciences, Inc.
Dec 6, 2022 08:00AM MilliporeSigma Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems Acquisition
Dec 1, 2022 06:45AM Merck to Present Data From Its Hematology Portfolio and Promising Pipeline at the 64th American Society of Hematology (ASH) Annual Meeting
Nov 29, 2022 11:41AM Merck Announces First-Quarter 2023 Dividend
Nov 22, 2022 06:50AM Merck (MRK) Announces Phase 3 KEYNOTE-859 Trial Met Primary Endpoint
Nov 22, 2022 06:45AM Merck Announces Phase 3 KEYNOTE-859 Trial Met Primary Endpoint of Overall Survival in Patients With HER2-Negative Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Nov 21, 2022 09:30AM Disney, Imago BioSciences rise premarket; Coinbase, Carvana fall
Nov 21, 2022 06:46AM Merck (MRK) Acquires Imago BioSciences (IMGO) for $36/sh or $1.35B
Nov 21, 2022 06:45AM Merck to Present at the 5th Annual Evercore ISI HealthCONx Conference
Nov 21, 2022 06:45AM Merck to Acquire Imago BioSciences, Inc.
Nov 16, 2022 08:00AM MilliporeSigma Invests $ 286 Million in U.S. Drug Safety Testing Capacity
Nov 14, 2022 06:46AM Merck's (MRK) LYNPARZA in Combination With Abiraterone and Prednisone or Prednisolone Recommended for Approval in EU
Nov 14, 2022 06:45AM LYNPARZA® (olaparib) in Combination With Abiraterone and Prednisone or Prednisolone Receives Positive Opinion From EU CHMP as Treatment for Certain Patients With Metastatic Castration-Resistant Prost
Nov 8, 2022 08:02AM Portage Biotech (PRTG) Announces Clinical Trial Collaboration Agreement with Merck (MRK)
Nov 7, 2022 06:45AM Reductions in Certain Types of HPV-Related Cervical and Non-Cervical Diseases in Women and Men Observed with Real-World Use of Merck's GARDASIL® in Systematic Literature Review of 138 Studies
Nov 1, 2022 07:10AM Veeva Systems (VEEV) and Merck (MRK) Enter Long-Term Strategic Partnership
Nov 1, 2022 07:03AM Veeva and Merck Form Long-Term Strategic Partnership
Oct 27, 2022 06:30AM Merck Announces Third-Quarter 2022 Financial Results
Oct 26, 2022 05:01PM Merck (MRK) Announces Robert M. Davis to Succeed Kenneth C. Frazier as Chairman
Oct 26, 2022 05:00PM Robert M. Davis to Succeed Kenneth C. Frazier as Chairman of Merck
Oct 24, 2022 06:46AM Merck (MRK) Granted Expanded EU VAXNEUVANCE Indication to Include Infants, Children and Adolescents
Oct 24, 2022 06:45AM European Commission Expands Merck’s VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) Indication to Include Infants, Children and Adolescents
Oct 24, 2022 05:52AM Merck (MRK) Reports Positive Phase 3 Data of PREVYMIS for Prevention of Cytomegalovirus Disease
Oct 22, 2022 03:00PM Merck’s PREVYMIS™ Demonstrates Efficacy in Phase 3 Study for Prevention of Cytomegalovirus Disease in Adults After Kidney Transplantation
Oct 18, 2022 09:07AM Merck Animal Health Launches Sure Petcare Animo® GPS
Oct 18, 2022 06:45AM Merck and the Bill & Melinda Gates Medical Research Institute Announce Licensing Agreement for Novel Tuberculosis Antibiotic Candidates
Oct 10, 2022 08:00AM Merck Recognized on Fortune’s 2022 Change the World List for Expanding Access to HPV Vaccines
Oct 10, 2022 06:46AM Merck (MRK) Reports Positive Top-line Results from Pivotal Phase 3 STELLAR Trial of Sotatercept
Oct 10, 2022 06:45AM Merck Announces Positive Top-line Results from Pivotal Phase 3 STELLAR Trial Evaluating Sotatercept for the Treatment of Adults with Pulmonary Arterial Hypertension (PAH)
Oct 7, 2022 06:12AM Merck (MRK) and Ridgeback Biotherapeutics Provide Update on New Studies of LAGEVRIO
Oct 6, 2022 07:50PM Merck and Ridgeback Biotherapeutics Provide Update on New Clinical and Non-Clinical Studies of LAGEVRIO™ (molnupiravir)
Oct 4, 2022 04:30AM MilliporeSigma Announces a Boost in Commercial Capacity in France as Part of New Millipore® CTDMO Services
Sep 29, 2022 03:23PM Merck (MRK) Announces U.S. Court of Appeals for Federal Circuit Rules in Favor of it in Sitagliptin Dihydrogen Phosphate Patent Lawsuit
Sep 29, 2022 03:22PM U.S. Court of Appeals for the Federal Circuit Rules in Favor of Merck in Sitagliptin Dihydrogen Phosphate Patent Lawsuit
Sep 29, 2022 06:45AM Merck to Hold Third-Quarter 2022 Sales and Earnings Conference Call October 27
Sep 27, 2022 07:00AM Merck Animal Health Completes Minority Investment in LeeO Precision Farming
Sep 27, 2022 06:45AM Merck (MRK) KEYTRUDA Granted Four New Approvals in Japan
Sep 27, 2022 06:45AM Merck’s KEYTRUDA® (pembrolizumab) Receives Four New Approvals in Japan, Including in High-Risk Early-Stage Triple-Negative Breast Cancer (TNBC)
Sep 22, 2022 07:30AM Merck Animal Health (MRK) to Acquire Vence
Sep 22, 2022 07:30AM Merck Animal Health to Acquire Vence
Sep 22, 2022 06:59AM Merck (MRK) Announces Court Ruling in Favor of Merck in Sitagliptin Phosphate Patent Lawsuit
Sep 22, 2022 06:45AM LYNPARZA® (olaparib) Approved in China as First-Line Maintenance Treatment With Bevacizumab for Homologous Recombination Deficient (HRD)-Positive Advanced Ovarian Cancer
Sep 22, 2022 06:40AM U.S. District Court Rules In Favor of Merck in Sitagliptin Phosphate Patent Lawsuit
Sep 20, 2022 06:46AM Merck (MRK) to Initiate New Phase 3 Trial with Lower Dose of Daily Oral Islatravir with Doravirine for Treatment of People with HIV-1 Infection
Sep 20, 2022 06:45AM Merck to Initiate New Phase 3 Clinical Program with Lower Dose of Daily Oral Islatravir in Combination with Doravirine for Treatment of People with HIV-1 Infection
Sep 16, 2022 07:30AM Merck (MRK) Receives Positive CHMP Opinion for VAXNEUVANCE
Sep 16, 2022 07:30AM Merck (MRK) Receives Positive CHMP Opinion for VAXNEUVANCE
Sep 16, 2022 07:30AM Merck Receives Positive CHMP Opinion for VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) in Infants and Children
Sep 12, 2022 08:56AM Seagen (SGEN), Merck (MRK) and Astellas Report Results of Trial Investigating PADCEV
View More Recent Stories View Older Stories